This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies The CHAI platform extracted quantitative histomorphologic features from whole-slide images of ...
Explore what is driving progress in neurological biomarker research today, from emerging technologies to clinical translation ...
Every decision in drug development carries weight. The right biomarker insights can make those decisions more confident and data-driven. In this white paper, experts from AstraZeneca, Johnson & ...
Priya Hays, Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and ...
Please provide your email address to receive an email when new articles are posted on . ADx NeuroSciences and Alamar Biosciences have announced a partnership to develop customized biomarker assays for ...
Opinion
Worcester Telegram on MSNOpinion
Opinion/Guest column: Biomarker tests right Rx for state's patients
Biomarker tests analyze a patient's underlying biology to help clinicians diagnose disease, monitor progression and identify best treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results